BioLineRx shares soar (again) on hep C pact; Anacor shares slide after GSK halts trials;

@FierceBiotech: Will $1B cancer IP theft suit trigger tighter vigilance on researchers' work? Article  | Follow @FierceBiotech

@JohnCFierce: So does BioLineRx see itself as a hep C co. now that it has in-licensed a 2nd program, or is this about share price? Release | Follow @JohnCFierce

@FierceMedDev: DNA-sequencing penetrates Norway's healthcare system. Story | Follow @FierceMedDev

@MarkHFierce: Dudes, eat lots of walnuts and your prostate cancer risk may shrink. It worked in mice, at least... More | Follow @MarkHFierce

> When Israel's BioLineRx announced a recent deal to in-license a preclinical hepatitis C drug from Genoscience, its shares soared on speculation that the move put the company in line for a potential takeover. This morning the biotech reported that it in-licensed a second preclinical hepatitis C drug from the same company, and its shares rocketed up 34%. And that is likely to underscore feelings among many that hep C stocks are becoming notoriously volatile. Release

> Anacor shares ($ANAC) tanked this morning after it announced that its partner GlaxoSmithKline ($GSK) had suspended four studies of GSK2251052, an anti-infection treatment. The suspension was triggered by a microbiological finding in some patients. Story

> Albion Ventures and Solon Ventures are injecting $2.4 million into Xceleron, a move that will help pay for the relocation of senior analytics staff to a new facility in Germantown, MD. Some of those staffers are coming from the U.K. Release

Pharma News

@FiercePharma: Could be big if it actually ends up working. RT @FierceMedDev: Depression diagnostic passes initial trial. Story | Follow @FiercePharma

IT News

> Researchers create software-based 3-D genome map. Story

> Supercomputing supports genetic, cancer research in Arizona. Article

> Median Technologies, Sanofi sign medical imaging deal. News

> Norway's sequencing project will need major IT infrastructure. More

> Oracle announces new round of projects in IT, clinical trials. Piece

Medical Device News

> Apollo Endosurgery secures $47.6M to launch surgical tools. News

> GAO report finds some hospitals paying more for devices. Report

> Smith & Nephew, Kensey Nash impress with earnings announcements. Article

> DNA-sequencing penetrates Norway's healthcare system. Story

> ALung scores $10M in Series B. News

And Finally... Investigators concluded that mesenchymal stem cells respond to exercise, which may help point to new treatments for muscle damage. Release